Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis

Oncology

Volumn 57, Issue 1, 1999, Pages 70-76

  Lundin, M ^b   Nordling, S ^b   Roberts, P J ^b   Lundin, J ^b   Carpelan Holmstrom M ^b   Von Boguslawsky, K ^b   Haglund, Caj ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NONE

Author keywords

Colorectal cancer; Immunohistochemistry; Prognosis; STn

Indexed keywords

MONOCLONAL ANTIBODY; SIALIC ACID DERIVATIVE;

ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032989963     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012003     Document Type: Article

References (27)

1. Hakomori S: Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res 1989;52:257-331.
2. Devine PL, McKenzie IF: Mucins: Structure, function, and association with malignancy. Bioessays 1992;14:619-625.
3. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim Y: Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993;53: 641-651.
4. Reddish M, Suresh M, Koganty R, Frotier S, Baronic L, Berg A, Longenecker M: Analysis of the role of type 1 core o-glycans in the binding of anti-MUC1 antibodies by cytofluorometry and synthetic peptide/glycopeptide binding inhibition studies. Tumor Biol 1998;19(suppl 1): 57-66.
5. Springer GF: T and Tn, general carcinoma autoantigens. Science 1984;224:1198-1206.
6. Schachter H, McGuire EJ, Roseman S: Sialic acids. 13. A uridine diphosphate D-galactose: Mucin galactosyltransferase from porcine submaxillary gland. J Biol Chem 1971;246:5321-5328.
7. Kjeldsen T, Clausen H, Hirohashi S: Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2-6a-N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Res 1988;48: 4361-4367.
8. Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS: Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 1989;49:197-204.
9. Örntoft TF, Harving N, Langkilde NC: O-Linked mucin-type glycoproteins in normal and malignant colon mucosa: Lack of T-antigen expression and accumulation of Tn and sialosyl-Tn antigens in carcinomas. Int J Cancer 1990;45:666-672.
10. Yonezawa S, Tachikawa T, Shin S, Sato E: Sialosyl-Tn antigen. Its distribution in normal human tissues and expression in adenocarcinomas. Am J Clin Pathol 1992;98:167-174.
11. Itzkowitz SH, Bloom EJ, Kokal WA, Modin G, Hakomori S, Kim YS: Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients. Cancer 1990;66: 1960-1966.
12. Victorzon M, Nordling S, Nilsson O, Roberts PJ, Haglund C: Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer. Int J Cancer 1996;65:295-300.
13. Yamada T, Watanabe A, Yamada Y, Shino Y, Tanase M, Yamashita J, Miwa T, Nakano H: Sialosyl Tn antigen expression is associated with the prognosis of patients with advanced gastric cancer. Cancer 1995;76:1529-1536.
14. Werther JL, Tatematsu M, Klein R, Kurihara M, Kumagai K, Llorens P, Guidugli Neto J, Bodian C, Pertsemlidis D, Yamachika T, Kitou T, Itzkowitz S: Sialosyl-Tn antigen as a marker of gastric cancer progression: An international study. Int J Cancer 1996;69:193-199.
15. Miles DW, Happerfield LC, Smith P, Gillibrand R, Bobrow LG, Gregory WM, Rubens RD: Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer. Br J Cancer 1994;70:1272-1275.
16. Kobayashi H, Terao T, Kawashima Y: Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer. J Clin Oncol 1992;10:95-101.
17. Victorzon M, Lundin J, Haglund C, Nordling S, Roberts PJ: A risk score for predicting outcome in patients with gastric cancer, based on stage, sialyl-Tn immunoreactivity and ploidy -A multivariate analysis. Int J Cancer 1996;67: 190-193.
18. Turnbull RB, Kyle K, Watson FR, Spratt J: Cancer of the colon: The influence of the no-touch isolation technic on survival rates. Ann Surg 1967;166:420-427.
19. Jass JR, Sobin LH: World Health Organization International Histological Classification of Tumors: Histological Typing of Intestinal Tumors, ed 2, New York, Springer, 1989.
20. Cox DR: Regression models and life tables. J Roy Statist Soc 1972;B34:187-220.
21. Dabelsteen E: Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 1996;179:358-369.
22. Podolsky DK: Oligosaccharide structures of human colonic mucin. J Biol Chem 1985;260: 8262-8271.
23. Podolsky DK: Oligosaccharide structures of isolated human colonic mucin species. J Biol Chem 1985;260:15510-15515.
24. Jass JR, Allison LJ, Edgar SG: Distribution of sialosyl Tn and Tn antigens within normal and malignant colorectal epithelium. J Pathol 1995;176:143-149.
25. Zhang S, Walberg LA, Ogata S, Itzkowitz SH, Koganty RR, Reddish M, Gandhi SS, Longenecker BM, Lloyd KO, Livingston PO: Immune sera and monoclonal antibodies define two configurations for the sialyl Tn tumor antigen. Cancer Res 1995;55:3364-3368.
26. Ogata S, Koganty R, Reddish M, Longenecker BM, Chen A, Perez C, Itzkowitz SH: Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa. Glycoconj J 1998;15:29-35.
27. Ogata S, Ho I, Chen A, Dubois D, Maklansky J, Singhal A, Hakomori S, Itzkowitz SH: Tumor-associated sialylated antigens are constitutively expressed in normal human colonic mucosa. Cancer Res 1995;55:1869-1874.